Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu Injection for STEMI Patients Undergoing Primary PCI
ChiCTR2600129490Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of shenfu injection in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Composite endpoint of MACEs. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
shenfu injection
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ChiCTR2600129490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129490.